Table 1 Summary of the participants
Case | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
Age (years) | 11 | 8 | 12 | 8 | 7 |
Sex (male/female) | M | M | M | M | F |
Food | Egg | Egg | Egg | Wheat | Cow’s milk |
Study phase at the start of LTRAs administration | Rush | Rush | Rush | Rush | M. P. |
Frequencies/dose of AS before administration of LTRAs | 0.47 | 0.57 | 0.29 | 0.50 | 0.93 |
Duration (days) of persistent AS before administration of LTRAs | 6 | 4 | 5 | 4 | 7 |
Specific IgE level (UA/mL) before administration of LTRAs | 25.1 | 12.7 | 9.61 | 78.1 | 0.90 |
Specific IgE level (UA/mL) after administration of LTRAs | 19.7 | 12.0 | 7.86 | 52.2 | 0.73 |
Treatment period (months) of LTRAs | 5 | 6 | 2 | 5 | 5 |